Browsing Tag
MiniMed
3 posts
A $560m test for the diabetes device market as MiniMed prepares to trade on Nasdaq
MiniMed prices its IPO at $20 per share, raising $560M as Medtronic plc spins out its diabetes unit. Discover what the move means for the diabetes technology market.
From Medtronic to the market: What MiniMed’s IPO means for CGM and insulin pump competition
Medtronic files IPO for MiniMed, its diabetes device business. Find out what this spin-off could mean for the future of CGM and insulin delivery tech.
MiniMed IPO: Medtronic (NYSE: MDT) to separate diabetes business with Nasdaq filing under MMED
Medtronic files IPO for MiniMed, its diabetes business. Find out what the Nasdaq listing means for the company’s strategy, margins, and the diabetes tech sector.